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Summary. The p53 gene encodes for a protein, p53, 
which plays a critical role in controlling the cell cycle, in 
DNA repair and in programed cell death (apoptosis). p53 
is one of the most frequently mutated genes in human 
neoplasms and a variety of techniques have been 
developed to detect these mutations. These range from 
advanced molecular-genetic analyses to immuno- 
histochemical staining for the p53 protein. This review 
will summarize our current understanding of the 
function of p53 as well as current methods to detect 
dysfunctional p53 and the clinical value of such 
analyses. 
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Introduction 
The p53 tumor-suppressor gene is the most 
frequently altered gene in human malignancies (Levine, 
1992; Wynford-Thomas, 1996). It is located on the short 
arm of chromosome 17 and encodes a 53 kD nuclear 
phosphoprotein called p53. Knowledge of the biological 
function of p53 and the molecular mechanisms through 
which p53 exerts its function will not only provide a 
better understanding of the process of carcinogenesis, 
but will also help identify new molecular targets which 
can be used to aid in the diagnosis of cancer and which 
may be of value in the management of cancer patients. 
Since p53 is functionally inactivated in the majority 
of human cancers, this may have major clinical 
implications. The authors will review the basic features 
of p53 function and its clinical relevance. 
Functions of wild-type p53 
The prominent role of p53 dysfunction in tumori- 
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genesis can be understood if one appreciates the 
importance of wild-type p53 in cell cycle regulation 
(Fig. 1). The main function of wild-type p53 is to protect 
the cell against DNA damage by preventing replication 
following DNA damage. Cell division with damaged 
DNA would lead to fixation of the damage, resulting in 
increased genomic instability and sensitivity of the cell 
to further DNA damage. Because of this protective 
function, p53 has been nicknamed the "Guardian of the 
genome" (Lane, 1992). 
Wild-type p53 operates through at least three dif- 
ferent molecular mechanisms (Harris, 1996) (Fig. 1). 
First, p53 acts as a checkpoint for DNA damage in cell 
cycle progression at the transition from G1 to S phase 
(Nishida et al., 1997). If the DNA is damaged, p53 
accumulates and acts as a transcription factor for p21 
(also called Cipl or wafl). p21 is a nuclear protein that 
can bind to cyclin-dependent kinases and thereby inacti- 
vate them (Xiong et al., 1993). Cyclin-dependent kinases 
are enzymes involved in the control of cell cycle 
progression. Interaction of p21 with the cyclin- 
dependent kinases, guided by p53, results in cell cycle 
arrest. This arrest creates time for DNA repair to occur 
prior to the cell entering S phase and thus damaged DNA 
will be repaired before it is replicated (Fig. 1) (Kern, 
1994). Second, in addition to providing time for DNA 
repair, p53 is also directly involved in DNA repair itself. 
p53 turns on the DNA repair machinery in the cell by 
interacting with several cellular proteins (Harris, 1996). 
These proteins include: "Proliferating Cell Nuclear 
Antigen" (PCNA, required for copying and repair of 
DNA), "Excision Repair Cross-Complementing 3 
protein" (ERCC3, an excision repair enzyme that partici- 
pates in the removal of damaged DNA) and "Growth 
Arrest DNA Damage inducible protein7' (GADD45, 
which complexes with PCNA and thereby stimulates its 
activity). Finally, if DNA damage is severe, p53 pushes 
the cell into programmed cell death (apoptosis). By 
promoting apoptosis, p53 ensures that severely damaged 
DNA will not be duplicated and that the damage will not 
be fixed into genomic material. For this function, p53 
interacts with two of the main mediators of apoptosis, 
Bcl-2 and Bax (Harris, 1996). 





